| Zenlabs Ethica Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 530697 |
NSE Symbol : - |
P/E(TTM) : 66.32 |
|
ISIN Demat : INE546F01013 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.38 |
|
Book Value(₹) : 16.21 |
Market Cap(₹Cr) : 16.41 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 12.43 | 11.48 | 12.99 | 12.72 | 13.35 | 12.36 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 12.43 | 11.48 | 12.99 | 12.72 | 13.35 | 12.36 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.06 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 |
| Total Income | 12.49 | 11.48 | 13.03 | 12.73 | 13.35 | 12.37 |
| Total Expenditure | 11.99 | 10.93 | 12.33 | 12.04 | 12.73 | 11.75 |
| PBIDT | 0.51 | 0.55 | 0.70 | 0.68 | 0.62 | 0.62 |
| Interest | 0.19 | 0.21 | 0.23 | 0.24 | 0.23 | 0.23 |
| PBDT | 0.32 | 0.34 | 0.47 | 0.44 | 0.39 | 0.39 |
| Depreciation | 0.24 | 0.29 | 0.31 | 0.32 | 0.31 | 0.32 |
| Tax | 0.02 | 0.00 | 0.05 | 0.04 | 0.02 | 0.02 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.02 | 0.01 | 0.02 | 0.00 | 0.00 | 0.01 |
| Reported Profit After Tax | 0.04 | 0.03 | 0.09 | 0.09 | 0.05 | 0.04 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.04 | 0.03 | 0.09 | 0.09 | 0.05 | 0.04 |
| EPS (Unit Curr.) | 0.06 | 0.05 | 0.14 | 0.13 | 0.08 | 0.06 |
| EPS (Adj) (Unit Curr.) | 0.06 | 0.05 | 0.14 | 0.13 | 0.08 | 0.06 |
| Calculated EPS (Unit Curr.) | 0.06 | 0.05 | 0.14 | 0.13 | 0.08 | 0.06 |
| Calculated EPS (Adj) (Unit Curr.) | 0.06 | 0.05 | 0.14 | 0.13 | 0.08 | 0.06 |
| Calculated EPS (Ann.) (Unit Curr.) | 0.23 | 0.20 | 0.56 | 0.52 | 0.32 | 0.26 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 0.23 | 0.20 | 0.56 | 0.52 | 0.32 | 0.26 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 6.51 | 6.51 | 6.51 | 6.51 | 6.51 | 6.51 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 4.10 | 4.79 | 5.39 | 5.35 | 4.64 | 5.02 |
| PBDTM(%) | 2.57 | 2.96 | 3.62 | 3.46 | 2.92 | 3.16 |
| PATM(%) | 0.32 | 0.26 | 0.69 | 0.71 | 0.37 | 0.32 |